MRK  Merck & Company Inc.

Exchange

NYSE

Sector

Consumer Durables

Industry

Major Pharmaceuticals

Market Cap.

142.0B

Vuru Grade

45.77/100

Current Price

$47.04
-0.29 (-0.61%)

Growth Price

$39.81
Overvalued by 15.37%

Stability Price

$17.04
Overvalued by 63.77%

Company Metrics

  • 24.15 P/E
  • 3.09 P/S
  • 2.69 P/B
  • 1.96 EPS
  • 13.83% Cash ROIC
  • 0.92 Cash Ratio
  • 1.7 / 3.59% Dividend
  • 16.80M Avg. Vol.
  • 3.02B Shares
  • 142.0B Market Cap.

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company's Pharmaceutical segment provides human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of bone, respiratory, immunology, dermatology, cardiovascular, ...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

MERCK & CO., INC. : Merck Statement on FDA Advisory Committee Meeting for ...
4-traders (press release) - 3 hours ago
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S.
FDA panel backs experimental Merck insomnia drug - TheNewsTribune.com
New sleep pill may be unsafe at higher doses, FDA review suggests - NBCNews.com (blog)
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Teva Pharmaceutical Industries Ltd ...
Insider Monkey (blog) - 9 hours ago
Emerging markets like China are proving to be a big boon for Merck & Co., Inc. (NYSE:MRK) as evidenced by the region's 6% year over year growth.
Merck signs $5 billion share buyback agreement with Goldman Sachs
Reuters - May 22, 2013
(Reuters) - Merck & Co Inc said it has entered into a $5 billion share repurchase agreement with Goldman Sachs Group Inc, as the drug giant looks to prop up shareholder value in face of stiff competition from makers of less-costly generics.
Medtronic, Inc. (MDT), Merck & Co., Inc. (MRK), AutoZone, Inc. (AZO): Today's ...
Insider Monkey (blog) - May 21, 2013
Medtronic, Inc. (NYSE:MDT) There's hardly any certainty in the market, but even I have to admit it's become almost comical that the Nasdaq Composite has hit a new high (including intraday highs) in 17 straight sessions while the broad-based S&P 500 ...
Merck To Repurchase $5B Shares From Goldman Sachs
ValueWalk - 10 hours ago
Drugmaker Merck & Co., Inc. (NYSE:MRK) today unveiled an accelerated share buyback program worth $5 billion. The country's second largest pharmaceutical company said it has reached a deal to buy 99.5 million of its own shares from Goldman Sachs ...
MERCK & CO., INC. : Merck Announces $5 Billion Accelerated Share Repurchase - 4-traders (press release)
Market News: Ford, Sony Corporation, Merck & Co, NetApp Inc., Saks Inc
ValueWalk - 5 hours ago
Stocks that were active in U.S. trading on Wednesday include Merck & Co., Inc. (NYSE:MRK), NetApp Inc. (NASDAQ:NTAP), Saks Inc (NYSE:SKS), Sony Corporation (NYSE:SNE) (TYO:6758) and Ford Motor Company (NYSE:F).
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK), Merck & Co ...
Insider Monkey (blog) - 9 hours ago
5: AbbVie Inc (NYSE:ABBV), 3.4% dividend yield AbbVie Inc (NYSE:ABBV) opens up the top five dividend stocks in big pharma with its 3.4% dividend yield, an offering that few income investors would turn down.
Merck & Co., Inc. (MRK): What Happened?
Insider Monkey (blog) - May 21, 2013
Merck & Co., Inc. (NYSE:MRK) Federal Reserve officials seem to be having a running internal debate about the efficacy and future of quantitative easing.
Why The Dow Jones Industrial Average Laggard Is An Important Leading Indicator - ETF Daily News
Stock Market News for May 22, 2013 - Market News - NASDAQ
Merck & Co., Inc. (MRK), Alcoa Inc (AA): Dow (.DJI) Sputters as Rally Runs Out ...
Insider Monkey (blog) - May 21, 2013
Merck & Co., Inc. Turning to the Dow, Merck & Co., Inc. (NYSE:MRK) was the worst performer, falling 1.7% after FDA reviewers questioned dosage levels in a new sleep aid drug.
Cisco Systems, Inc. (CSCO), Merck & Co., Inc. (MRK), The Coca-Cola Company ...
Insider Monkey (blog) - May 20, 2013
Merck & Co., Inc. (NYSE:MRK) has also dropped, falling 1.4% after the FDA expressed concerns about the side effects of the company's suvorexant insomnia drug.